4 years ago

ClinSpec Diagnostics Secures £3.5M Funding for Early Cancer Detection Technology

  • ClinSpec Diagnostics, a Glasgow-based developer of liquid biopsies for early cancer detection, has secured an additional £1.1M in funding, bringing its total raise to £3.5M

  • The investment was led by Norcliffe Capital Limited, with participation from the University of Strathclyde, Eos Advisory, and the founders

  • This follows an initial £2.4M investment in 2020 led by Mercia’s EIS Funds, with participation from Scottish Enterprise, SIS Ventures, Eos Advisory, and the University of Strathclyde

  • The company has raised a total of £5.1M to date, including seed funding in 2019 and grants from Higgs EDGE Special Award and Innovate UK.

      • ProblemHealthcare

      "early detection of cancer using minimal invasive methods"

      Solution

      "liquid biopsies using combination of infra-red light and artificial intelligence"

      Covered on